Approach to inborn errors of metabolism presenting in the neonate

Suvasini Sharma1, Pradeep Kumar, Ramesh Agarwal

  • 1Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

Insights

Inborn errors of metabolism (IEM) cause severe newborn illness, often mimicking sepsis. Early detection via biochemical markers like blood ammonia is crucial for timely treatment and genetic counseling.

Area of Science:

  • Biochemistry
  • Neonatal Medicine
  • Genetics

Background:

  • Inborn errors of metabolism (IEM) are a significant cause of acute neonatal illness.
  • IEM presentations can resemble common neonatal conditions, such as sepsis, complicating diagnosis.
  • A high index of suspicion is necessary for prompt identification.

Purpose of the Study:

  • To describe guidelines for the diagnosis and early management of IEM in newborns.
  • To emphasize the importance of early biochemical marker measurement, like blood ammonia levels.
  • To highlight the role of diagnosis in guiding treatment and genetic counseling.

Main Methods:

  • Review and synthesis of existing diagnostic and management guidelines for neonatal IEM.
  • Emphasis on the clinical presentation and differential diagnosis, including sepsis.
  • Focus on key biochemical markers for early detection.

Main Results:

  • IEM requires prompt recognition due to potential for acute illness in newborns.
  • Early biochemical testing, including blood ammonia, is vital for diagnosis.
  • Accurate diagnosis facilitates appropriate treatment and genetic counseling.

Conclusions:

  • Guidelines for diagnosing and managing neonatal IEM are essential.
  • Early detection and intervention in IEM improve outcomes.
  • Understanding IEM is critical for neonatal care and family planning.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...